Mifepristone Safety Report Due by March 2027 as FDA Compares Insurance Claims for Pill and Surgical Abortion
The FDA expects initial mifepristone safety-analysis results in December and plans to complete its report by March 2027. Current prescribing and telehealth rules remain unchanged.
Medical Daily ·